New Health Technologies: A UK Perspective Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies"

被引：2
|
作者：
Parvizi, Nassim [1 ]
Parvizi, Sahar [2 ]
机构：
[1] Oxford Univ Hosp NHS Fdn Trust, Oxford, England
[2] Moorfields Eye Hosp NHS Fdn Trust, London, England
来源：
INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT | 2017年 / 6卷 / 12期
关键词：
Health Technology; Health Technology Assessment (HTA); National Institute of Health Research (NIHR); National Institute for Health and Care Excellence (NICE);
D O I：
10.15171/ijhpm.2017.59
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
New health technologies require development and evaluation ahead of being incorporated into the patient care pathway. In light of the recent publication by Lehoux et al who discuss the role of entrepreneurs, investors and regulators in providing value to new health technologies, we summarise the processes involved in making new health technologies available for use in the United Kingdom.
引用
收藏
页码：721 / 722
页数：2
相关论文
共 50 条
12345